Back to HZNP Stock Lookup

Horizon Therapeutics (HZNP) – StreetInsider.com Reports

Jul 21, 2021 08:49 AM Cowen Pounds the Table on Horizon Therapeutics (HZNP), Says Add to Positions Before Earnings
Jun 29, 2021 08:02 AM Horizon Therapeutics (HZNP) Enrolls First Patient in Phase 2 Trial of HZN-7734 for the Treatment of Systemic Lupus Erythematosus
Jun 23, 2021 09:18 AM Horizon Therapeutics (HZNP) Survey Implies CAGR >20% - Piper Sandler
Jun 21, 2021 08:13 AM Horizon Therapeutics' (HZNP) KOL Call Shows Tepezza Use Broadening Among Clinicians - Jefferies
Jun 21, 2021 07:32 AM Arrowhead Pharmaceuticals (ARWR), Horizon Therapeutics (HZNP) Announce Collaboration to Develop RNAi Therapeutic for Uncontrolled Gout
Jun 18, 2021 12:32 PM Horizon Therapeutics (HZNP) Announces Multiple Presentations on NMOSD at EAN
Jun 17, 2021 07:06 AM Horizon Therapeutics (HZNP) Announces Purchase of Manufacturing Facility to Support Growth of On-Market Rare Disease and Pipeline Biologics
Jun 9, 2021 09:44 AM Horizon Therapeutics (HZNP) Gains on Newsletter Pick
Jun 4, 2021 08:36 AM Horizon Therapeutics' (HZNP) Tepezza Sales Rebound in April, Commentary from the Jefferies Healthcare Conference
May 6, 2021 08:34 AM Horizon Therapeutics (HZNP) Announces New Analysis of UPLIZNA for Neuromyelitis Optica Spectrum Disorder Published in Neurology Neuroimmunology & Neuroinflammation
May 5, 2021 11:30 AM Horizon Therapeutics (HZNP) Tepezza is Now Underway, Add Stock - Cowen
May 5, 2021 07:12 AM Horizon Therapeutics (HZNP) Misses Q1 EPS by 13c, Offers FY Guidance
Apr 16, 2021 08:03 AM Horizon Therapeutics (HZNP) Announces New Integrated Data and Follow-up Outcomes From Two TEPEZZA Pivotal Trials Published in The Lancet Diabetes & Endocrinology
Apr 7, 2021 08:03 AM Horizon Therapeutics (HZNP) RECIPE Randomized Controlled Trial Data Published in Arthritis & Rheumatology Show Higher Response Rates Using KRYSTEXXA with Immunomodulator Mycophenolate Mofetil
Apr 5, 2021 08:36 AM Horizon Therapeutics (HZNP) Announces New UPLIZNA Data in People With Neuromyelitis Optica Spectrum Disorder to be Presented at AAN's 73rd Annual Meeting
Mar 30, 2021 07:34 AM Horizon Therapeutics (HZNP) to Resupply Market With TEPEZZA for the Treatment of Thyroid Eye Disease Beginning in April
Mar 25, 2021 06:21 AM Horizon Therapeutics (HZNP) PT Raised to $120 at Guggenheim
Mar 24, 2021 08:16 AM Horizon Therapeutics (HZNP) Announces UPLIZNA Approved by Japanese Ministry of Health, Labour and Welfare for the Prevention of Relapses of Neuromyelitis Optica Spectrum Disorder
Mar 22, 2021 08:51 AM Morgan Stanley Resumes Horizon Therapeutics (HZNP) at Overweight on Tepezza Opportunity
Mar 19, 2021 08:33 AM Horizon Therapeutics (HZNP) KOL Call Implies Tepezza Rebound - Jefferies
Mar 18, 2021 04:50 AM Citi Assumes Horizon Therapeutics (HZNP) at Buy
Mar 17, 2021 06:05 AM Horizon Therapeutics (HZNP) PT Raised to $125 at Stifel
Mar 11, 2021 04:58 PM UPDATE: Wolfe Research Starts Horizon Therapeutics (HZNP) at Outperform
Feb 24, 2021 05:34 PM Horizon Therapeutics (HZNP) PT Raised to $118 at BMO Capital
Feb 24, 2021 09:51 AM Horizon Therapeutics (HZNP) PT Raised to $120 at Cowen
Feb 24, 2021 07:08 AM Horizon Therapeutics (HZNP) Tops Q4 EPS by 22c, Revenues Beat; Offers FY21 Revenue Guidance Above Consensus
Feb 22, 2021 12:08 AM Horizon Therapeutics (HZNP) PT Raised to $115 at BMO Capital
Feb 17, 2021 09:23 AM Horizon Therapeutics (HZNP) PT Raised to $120 at Jefferies on VIE Transaction
Feb 16, 2021 05:30 PM Paulson's 13F shows new stakes in Occidental (OXY), Exxon (XOM), Alexion (ALXN), (more...)
Feb 9, 2021 07:35 AM Horizon Therapeutics (HZNP) PT Raised to $100 at BofA Securities After Including Viela
Feb 5, 2021 08:48 AM Horizon Therapeutics (HZNP) PT Raised to $125 at Piper Sandler
Feb 1, 2021 09:30 AM Pre-Open Stock Movers 02/01: (VIE) (THCB) (CDE) Higher; (QTNT) (NNOX) (GME) Lower (more...)
Feb 1, 2021 07:03 AM Horizon Therapeutics (HZNP) to Acquire Viela Bio (VIE) for $53 Per Share in $3.05 Billion Deal
Jan 11, 2021 07:04 AM Horizon Therapeutics (HZNP) Provides Preliminary 2020 Financial Results
Jan 7, 2021 07:19 AM Cowen's Tepezza Survey Confirms Investor Expectations Remain Low, Horizon Therapeutics (HZNP) PT Reiterated at $115
Dec 17, 2020 02:02 PM Stifel Defends Horizon Therapeutics (HZNP)
Dec 17, 2020 01:25 PM Horizon Therapeutics (HZNP) Tepezza Shortage 'Seems Manageable' - BMO
Dec 1, 2020 09:10 AM Horizon Therapeutics (HZNP) Reiterated as 'Buy' at BofA Following Recent Weakness in Price
Nov 23, 2020 08:05 AM Horizon Therapeutics (HZNP) and Halozyme Therapeutics (HALO) Enter Global Collaboration and License Agreement for ENHANZE® Technology
Nov 13, 2020 08:34 AM Horizon Therapeutics (HZNP) Reports New TEPEZZA (teprotumumab-trbw) Data Presented at AAO 2020 Virtual
Nov 3, 2020 08:05 AM Horizon Therapeutics (HZNP) PT Raised to $103 at Jefferies
Nov 3, 2020 07:05 AM Horizon Therapeutics (HZNP) PT Raised to $101 at BofA Securities
Nov 3, 2020 05:01 AM Horizon Therapeutics (HZNP) PT Raised to $116 at Citi
Nov 2, 2020 03:28 PM Horizon Therapeutics (HZNP) PT Raised to $110 at BMO Capital, Following Earnings
Nov 2, 2020 03:11 PM Horizon Therapeutics (HZNP) PT Raised to $108 at Stifel, Following Earnings
Nov 2, 2020 02:00 PM Horizon Therapeutics (HZNP) Higher Response Rates in RECIPE Randomized Controlled Trial of KRYSTEXXA Concomitantly Used with the Immunomodulator Mycophenolate Mofetil
Nov 2, 2020 10:14 AM Horizon Therapeutics (HZNP) PT Raised to $115 at Cowen Following Q3 Results
Nov 2, 2020 07:04 AM Horizon Therapeutics (HZNP) Tops Q3 EPS by 77c, Raises FY Revenue Guidance
Oct 16, 2020 09:04 AM Morgan Stanley highlights 15 'high conviction' names going into earnings season
Oct 14, 2020 08:03 AM Horizon Therapeutics (HZNP) Reports TEPEZZA (teprotumumab-trbw) Data from Phase 2 Clinical Trial Evaluate Longer-Term Responses in People Living with Thyroid Eye Disease

Back to HZNP Stock Lookup